AbCellera Biologics Inc.
ABCL | NASDAQ
$12.77
+$0.11 (+0.87%)
Sep 22, 2026, 10:32 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -98.59M | -43.17M | -8.95M | -57.12M | -34.73M | -45.62M | -34.21M | -51.11M | -36.93M | -40.61M | -47.15M | -28.61M | -30.53M | -40.11M | -29.89M | 26.62M | -6.79M | 168.57M | 59.95M | -21.38M | -2.32M | 117.22M |
Depreciation & Amortization | 5.17M | 8.66M | 8.99M | 7.24M | 7.06M | 6.61M | -18.1M | 38.3M | 38.04M | 6.77M | 9.11M | 7.41M | 7.26M | 7.12M | 15.36M | 6.73M | 6.04M | 4.97M | 4.86M | 4.21M | 4.22M | 3.97M |
Stock-Based Compensation | 12.29M | 12.01M | 12.9M | 13.9M | 14.21M | 14.79M | 15.23M | n/a | n/a | 17.41M | 16.45M | 15.86M | n/a | 15.47M | 13.32M | 11.75M | n/a | 12.29M | 9.04M | 7.71M | n/a | 5.43M |
Other Working Capital | 17.1M | -17.1M | -12.24M | -27.36M | 6.13M | 15.01M | 4.95M | 9.91M | 3.08M | -3.53M | 32.87M | 17.4M | 56.88M | -34.31M | -39.39M | -29.82M | -12.62M | 90.89M | 41.32M | -12.64M | -1.95M | -9.1M |
Other Non-Cash Items | 50.49M | 2.38M | -1.7M | 1.53M | -2.14M | 2.21M | 45M | -10.37M | -22.78M | 1.71M | -1.39M | -1.93M | 15.5M | -3.63M | 3.13M | -82.74M | 11.61M | -592K | 2.68M | 1.31M | 10.37M | -191K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.25M | -4.02M | 144.74K | 623K |
Change in Working Capital | -3.22M | -13.4M | -45.99M | -18.14M | -16.8M | 10.46M | -15.92M | -5.82M | -7.79M | -26.98M | 1.41M | 7.16M | 27.59M | -22.91M | 28.99M | -89.15M | 260.64M | -85.03M | -94.49M | 6.25M | 149.43M | -17.5M |
Operating Cash Flow | -33.86M | -33.52M | -34.74M | -52.59M | -32.4M | -11.55M | -8M | -29M | -29.46M | -41.71M | -19.61M | -106K | 19.82M | -44.06M | 30.91M | -126.79M | 271.51M | 100.22M | -16.71M | -5.93M | 161.83M | 109.55M |
Capital Expenditures | -2.13M | -3.83M | -9.84M | -8.93M | -13.37M | -10.64M | -15.63M | -18.58M | -19.8M | -24.14M | -14.43M | -20.33M | -27.35M | -14.98M | -12.33M | -12.51M | -31.14M | -14.5M | -9.43M | -8.57M | -37.43M | -3.64M |
Cash Acquisitions | n/a | n/a | -2.55M | -2.45M | -2.55M | -1.88M | -1.67M | n/a | n/a | -5.91M | -3.48M | -3.54M | n/a | -4.47M | -5.91M | n/a | n/a | n/a | -3.22M | -18.05M | n/a | n/a |
Purchase of Investments | -141.77M | -166.41M | -119.52M | -36.15M | -134.73M | -172.47M | -152.84M | -194.01M | -174.07M | -253.76M | -284.73M | -216.34M | -174.39M | -395.49M | -93.55M | n/a | -89.24M | -71.77M | -29.4M | -257.81M | -13.75M | -12.2M |
Sales Maturities Of Investments | -143.8M | 143.8M | 113.41M | 83.1M | 113.41M | 190.03M | 199.28M | 207.12M | 232.94M | 306.55M | 268.02M | 220.1M | 161.67M | 262.64M | 92.39M | n/a | 87.93M | 57.29M | 18.08M | 9.53M | n/a | n/a |
Other Investing Acitivies | 299.05M | 1.36M | 93.65M | 918K | 5.43M | 2.9M | 6.56M | 9.43M | 12.44M | 7.17M | 10.29M | 7.33M | 5.03M | 2.69M | 2.33M | -269.48M | 5.47M | 2.6M | 22.81M | 5.29M | 4.59M | n/a |
Investing Cash Flow | 11.34M | -25.08M | 75.14M | 36.49M | -31.81M | 7.94M | 35.7M | 3.94M | 51.52M | 29.91M | -24.32M | -12.79M | -35.04M | -149.61M | -17.06M | -281.99M | -26.98M | -26.37M | -1.15M | -269.63M | -46.59M | -15.84M |
Debt Repayment | n/a | 7.19M | 10.52M | 7.55M | 5.51M | 6.15M | 5.9M | -4.47M | 2.34M | 2.12M | 3.95M | 7.03M | 1.59M | 490K | 2.76M | 231K | -705.89 | -72K | n/a | n/a | 750.23K | -1.72M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -1.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 13.59M | n/a | -6.41M | -182K | -8.88M | -178K | -177K | 7.38M | -180.4K | -185K | -185K | -374.02K | -679.39K | -948K | -2.41M | -250K | 956.36K | -5M | 1.83M | 898K | -7.67M | n/a |
Financial Cash Flow | 13.59M | 7.19M | 4.12M | 7.37M | -3.38M | 5.97M | 4.14M | 3.15M | 2.61M | 2.83M | 3.77M | 6.63M | 418.86K | -458K | 349K | -19K | 1.18M | -3.13M | 1.83M | 898K | -5.18M | -1.54M |
Net Cash Flow | -7.87M | -52.95M | 44.8M | -9.28M | -66.83M | 2.94M | 29.69M | -21.67M | 24.74M | -9.75M | -39.1M | -7.33M | -13.27M | -194.34M | 14.56M | -417.35M | 244.9M | 69.58M | -16.55M | -274.88M | 106.78M | 91.68M |
Free Cash Flow | -36M | -37.35M | -44.59M | -61.52M | -45.77M | -22.19M | -23.63M | -47.58M | -49.26M | -65.85M | -34.04M | -20.44M | -7.53M | -59.05M | 18.58M | -139.3M | 240.37M | 85.72M | -26.14M | -14.51M | 124.4M | 105.9M |
Adj. Free Cash Flow | -48.28M | -49.37M | -57.49M | -75.42M | -59.98M | -36.98M | -38.86M | -47.58M | -49.26M | -83.26M | -50.49M | -36.3M | -7.53M | -74.52M | 5.26M | -151.05M | 240.37M | 73.43M | -35.18M | -22.21M | 124.4M | 100.47M |
Maintenance CapEx | -2.13M | -3.83M | n/a | -6.16M | -2.32M | -10.64M | -15.63M | -18.58M | -19.8M | -24.14M | -14.43M | -20.33M | -27.35M | -14.98M | -12.33M | n/a | -25.21M | n/a | -9.43M | -8.57M | -33.66M | n/a |
Growth CapEx | n/a | n/a | -9.84M | -2.77M | -11.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.51M | -5.93M | -14.5M | n/a | n/a | -3.77M | -3.64M |
Owner Earnings | -36M | -37.35M | -34.74M | -58.75M | -34.72M | -22.19M | -23.63M | -47.58M | -49.26M | -65.85M | -34.04M | -20.44M | -7.53M | -59.05M | 18.58M | -126.79M | 246.3M | 100.22M | -26.14M | -14.51M | 128.17M | 109.55M |
Add to Watchlist
Select watchlists to add or remove ABCL